Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.
Boston Scientific (BSX) is attracting bullish analyst attention after its strategic acquisition of Penumbra, with Truist Securities reiterating a Buy rating and a $120 price target, citing enhanced business durability and growth prospects.
A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.
Driven by falling costs and strong incentives, heavy manufacturing is increasingly turning to on-site solar power. This shift is transforming large factory roofs from passive structures into strategic assets for cutting energy bills and emissions.
While Booz Allen Hamilton's Q4 revenue fell short of expectations, robust profitability and a strategic shift toward outcome-based contracts in high-demand sectors like cybersecurity spurred investor optimism. Analysts pressed management on the sustainability of this model and the path forward in a complex funding environment.
OneWater Marine's Q4 results reveal a company successfully steering through a challenging market. While revenue growth was minimal, strategic inventory management and a focus on higher-margin segments led to significant profit improvement, offering a blueprint for resilience in the marine industry.
Navios Maritime Partners (NMM) has delivered impressive multi-year returns, leaving investors to question if its current valuation still presents an opportunity. With a diversified fleet and strong fundamentals, we examine the bull case and the risks ahead.
Charter Communications reversed a year-long decline in its pay-TV business, adding 44,000 video subscribers in Q4. The unexpected turnaround, driven by simplified pricing and bundled streaming, offers a rare bright spot for a sector grappling with soaring costs and cord-cutting.
As hyperscalers seek alternatives to expensive GPUs, Broadcom's custom chip design expertise positions it to capture a massive share of the projected $1.4 trillion data center capex market by 2030.
Despite a slight uptick in earnings per share, CDW Corporation's stock has plummeted over 38% in three years, starkly underperforming a surging market and leaving investors questioning the disconnect between financial performance and share price.
Despite significant capital investment, Atmos Energy's return on capital employed (ROCE) remains stagnant at 5.9%, trailing the industry average. This raises questions about the utility's growth efficiency, even as its stock price has soared over 112% in five years.
While Exelon's recent earnings beat expectations, the utility giant continues to face investor skepticism over its long-term growth trajectory. Wall Street maintains a guarded optimism, but the stock's performance tells a more nuanced story.
While Q3 earnings reflect challenging market conditions, the chemical giant reports strong North American performance and accelerates its strategic shift, breaking ground on a flagship advanced recycling plant in Germany and planning a larger facility in Houston.
Facing what CEO Peter Vanacker calls the 'deepest and longest downturn' of his career, LyondellBasell reported Q1 2025 results while detailing a new $500 million cash improvement plan. The chemical giant is leaning into portfolio restructuring and its global supply network to weather trade policy uncertainty and weak demand.
Facing one of the longest downturns in industry history, LyondellBasell reported Q2 2025 earnings of $0.62 per share, outlining a disciplined strategy focused on cash conservation, portfolio optimization in Europe, and a pivot towards circular and low-carbon solutions to emerge stronger from the cycle.
President Donald Trump's selection of former Fed Governor Kevin Warsh to lead the central bank is being welcomed by analysts as a stabilizing choice, with immediate positive ripples across currency and precious metals markets.
While rising crude prices have lifted Occidental Petroleum's stock recently, a mixed earnings performance and a predominantly 'Hold' rating from Wall Street signal lingering skepticism about its near-term trajectory.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Verizon Communications posts its strongest customer gains since 2019, bolstered by a key fiber acquisition and a renewed strategic focus under CEO Hans Vestberg, signaling a potential inflection point for the telecom giant.
